Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RetaXome Daily Retinal Hydrator
- Development stage
- Unknown
- Lead developer
- Hydrinity
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
- Administration
- Topical
01
Overview
RetaXome Daily Retinal Hydrator is a topical cosmetic skincare product developed by Hydrinity Accelerated Skin Science. It utilizes proprietary RetaXome Technology, which involves the encapsulation of stabilized retinal (retinaldehyde) within biomimetic exosomes. This delivery system is designed to transport the active ingredient deep into the skin while maintaining its potency and minimizing irritation. Retinal is a potent retinoid that requires only a single enzymatic conversion step to become active retinoic acid, thereby promoting cellular turnover and stimulating the production of collagen and elastin. The product is indicated for the improvement of fine lines, wrinkles, skin texture, and hydration, and is designed for nightly use without an acclimation period.
- Brand names
- RetaXome Daily Retinal HydratorRetaXome
- Other names
- RetaXome Daily Retinal Hydrator
02
Targets
RAR (Retinoic acid receptor)
Beyond the preview
Go deeper on RetaXome Daily Retinal Hydrator.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RetaXome Daily Retinal Hydrator.